Avant Diagnostics (AVDX): An Ounce of Prevention i
Post# of 104
Posted On: 11/24/2015 4:12:37 PM
Avant Diagnostics (AVDX): An Ounce of Prevention is Worth a Pound of Cure
Early detection of cancer is the key to using the medicines available today to battle cancer and give the patient the best chance of beating this horrible disease and getting back to a normal life. Avant Diagnostics (AVDX) has undertaken this heroic challenge with its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test.
OvaDx is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development.
Each year, cancer costs the world more money than any other disease, according to the American Institute of Cancer Research (AICR).
Cancer costs $895 billion annually. Comparatively, heart disease costs $753 billion. Nothing else comes close, with traffic accidents and diabetes each costing about $204 billion. More than half a million Americans die of cancer, the second-leading cause of death in the U.S., every year.
Cancer is like any disease, ailment, or problem in that the earlier you correctly identify and get to work on fixing it, the better your chances are… Let’s just use Peyton Manning as a good example of what to do. When he throws an interception, he immediately goes to the sideline, talks to coaches, studies stills of defensive alignments and identifies what he could have done better to throw a touchdown instead of the interception.
Using a product like OvaDx would be the best way to identify the exact nature of the problem, so experts and doctors can recommend the best treatments to ensure your survival. Cancer does not discriminate, as you can see from the above study, and takes very few prisoners, especially when you sit back and do nothing. Companies developing state of the art technology like AVDX give patients the best chance at beating this horrible disease and living a long and happy life.
In conclusion, put AVDX on your radar, especially considering recent FDA developments. It would be well worth your time to educate yourself a little more on early cancer detection and participate in the battle affecting everyone in the world today.
For more information, visit www.avantdiagnostics.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Early detection of cancer is the key to using the medicines available today to battle cancer and give the patient the best chance of beating this horrible disease and getting back to a normal life. Avant Diagnostics (AVDX) has undertaken this heroic challenge with its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test.
OvaDx is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development.
Each year, cancer costs the world more money than any other disease, according to the American Institute of Cancer Research (AICR).
Cancer costs $895 billion annually. Comparatively, heart disease costs $753 billion. Nothing else comes close, with traffic accidents and diabetes each costing about $204 billion. More than half a million Americans die of cancer, the second-leading cause of death in the U.S., every year.
Cancer is like any disease, ailment, or problem in that the earlier you correctly identify and get to work on fixing it, the better your chances are… Let’s just use Peyton Manning as a good example of what to do. When he throws an interception, he immediately goes to the sideline, talks to coaches, studies stills of defensive alignments and identifies what he could have done better to throw a touchdown instead of the interception.
Using a product like OvaDx would be the best way to identify the exact nature of the problem, so experts and doctors can recommend the best treatments to ensure your survival. Cancer does not discriminate, as you can see from the above study, and takes very few prisoners, especially when you sit back and do nothing. Companies developing state of the art technology like AVDX give patients the best chance at beating this horrible disease and living a long and happy life.
In conclusion, put AVDX on your radar, especially considering recent FDA developments. It would be well worth your time to educate yourself a little more on early cancer detection and participate in the battle affecting everyone in the world today.
For more information, visit www.avantdiagnostics.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)